CELLINK speaks of breakthrough in Bioprinting at an international conference

CELLINK speaks at the 2nd International Conference on 3D Printing in Medicine in Mainz, Germany.

CELLINK's Bioink officer, Dr. Thayer, speaks about the two recent break throughs in soft tissue bioprinting in collaboration with researchers at Sahlgrenska University Hospital and Chalmers University of Technology as published in the Plastic and Reconstructive Surgery Global Open and Scientific Reports.

The first study that was conducted utilizing CELLINK's patent-pending Bioink and Bioprinter was the world's first in vivo evaluation of bioprinted cartilage while the second one utilized CELLINK's bioink together with human iPS cells to form cartilage in vitro. 

For further information, please contact: 

Erik Gatenholm, CEO                                       Gusten Danielsson, CFO
Phone: +46 73 267 00 00                                Phone: +46 70 991 86 04
Email: eg@cellink.com                                     Email: gd@cellink.com 

About CELLINK 

CELLINK has created one of the world's first universal Bioinks currently used by many of the world's most renowned research institutions. A Bioink can be mixed with living cells to print functional human tissues and if future research is successful, eventually, complete human organs in 3D-Bioprinters. CELLINKs universal Bioink show excellent results and can be used in both CELLINKs proprietary 3D Bioprinters and its’ competitors. Mangold Fondkommission AB, Phone: +46 8 5030 1550, the Certified Adviser.